• N/A
    Market Cap
  • 18.00%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
17.3M
+76.06%
9.8M
+38,359.19%
25,536
+978.83%
2,367
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
22,096
+1,778.91%
1,176
N/A
Gross Profit
17.3M
+76.06%
9.8M
+285,392.44%
3,440
+188.83%
1,191
N/A
Sales and Marketing Expense
1.5M
-27.04%
2.0M
-22.43%
2.6M
-9.38%
2.9M
N/A
Research and Development Expense
-793,327
-10.24%
-883,866
-37.06%
-1.4M
+191.27%
-482,141
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
2.9M
-15.55%
3.4M
-29.17%
4.8M
+68.02%
2.9M
N/A
Operating Profit
-2.9M
-15.55%
-3.4M
-29.12%
-4.8M
-212.75%
4.3M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-19.7M
+58.84%
-12.4M
+392.73%
-2.5M
-60.29%
-6.4M
N/A
Interest Income and Expense and Net
-19.7M
+58.84%
-12.4M
+392.73%
-2.5M
-60.29%
-6.4M
N/A
Total Nonoperating Income and Expense
-19.2M
+53.83%
-12.5M
-594.36%
2.5M
-60.29%
6.4M
N/A
Income before Taxes
-2.9M
-15.55%
-3.4M
-29.12%
-4.8M
+12.78%
-4.3M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-22.1M
+38.92%
-15.9M
+229.82%
-4.8M
+12.78%
-4.3M
N/A
Net Income from Continuing Operations Applicable to Common
-2.3M
-114.22%
15.9M
+312.42%
-7.5M
-29.61%
-10.6M
N/A
Basic EPS and Net Income
N/A
N/A
-0.03
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-0.04
+33.33%
-0.03
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
607.0M
+1.35%
598.9M
N/A
N/A
N/A
N/A
N/A
Diluted Weighted Average Shares
607.0M
+1.35%
598.9M
N/A
N/A
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
20,305
-50.06%
40,657
-31.19%
59,082
-60.25%
148,628
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
20,305
-50.06%
40,657
-31.19%
59,082
-60.25%
148,628
N/A
Total Current Assets
36,531
-46.75%
68,609
-33.45%
103,098
-72.67%
377,289
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
47,374
-40.39%
79,472
-48.79%
155,198
-58.86%
377,289
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
29.2M
+19.42%
24.4M
+9.57%
22.3M
+26.24%
17.7M
N/A
Total Current Liabilities
3.6M
-14.15%
4.1M
-87.08%
32.1M
+18.39%
27.1M
N/A
Total Long-Term Debt
23.2M
+12.72%
20.6M
-2.23%
21.0M
+11.25%
18.9M
N/A
Total Long-Term Liabilities
24,000
0.00%
24,000
N/A
N/A
N/A
N/A
N/A
Total Liabilities
39.9M
+9.92%
36.3M
+13.20%
32.1M
+10.85%
28.9M
N/A
Retained Earnings
-158.0M
+16.22%
-136.0M
+13.22%
-120.1M
+6.64%
-112.6M
N/A
Total Stockholders Equity
-39.9M
+10.03%
-36.2M
+13.50%
-31.9M
+11.77%
-28.6M
N/A
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
552.0M
N/A
Cash Flow
Cash from Operating Activities
-1.9M
+21.34%
-1.5M
-5.05%
-1.6M
-21.94%
-2.1M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.8M
+21.47%
1.5M
-1.16%
1.5M
-23.47%
2.0M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
13.47%
N/A
N/A
N/A
Operating Margin
-16.66%
-52.03%
-34.74%
-99.82%
-18,851.70%
N/A
N/A
N/A
Return on Assets
-34,778.85%
+157.02%
-13,531.78%
+648.39%
-1,808.11%
N/A
N/A
N/A
Return on Equity
57.98%
+24.42%
46.60%
+192.70%
15.92%
N/A
N/A
N/A
Revenue Growth
76.06%
-99.80%
38,359.19%
+3,818.87%
978.83%
N/A
N/A
N/A
Current Ratio
0.01
-37.95%
0.02
+418.75%
0.003
N/A
N/A
N/A
Cash Ratio
0.006
-41.84%
0.010
+444.44%
0.002
N/A
N/A
N/A
Debt-to-Equity Ratio
-1.31
+5.74%
-1.24
-8.50%
-1.36
N/A
N/A
N/A
Debt-to-Assets Ratio
1,105.78
+95.19%
566.51
+102.79%
279.36
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow